Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
D000241:Adenosine / Q000494:pharmacology*; D000328:Adult; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D001565:Benzoates / Q000494:pharmacology*; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D004347:Drug Interactions; D005029:Ethylenediamines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D001565:Benzoates; D005029:Ethylenediamines; D014665:Vasodilator Agents; D000628:Aminophylline; D000241:Adenosine